Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Kestra Medical Technologies, Ltd. (KMTS) vs LeMaitre Vascular, Inc. (LMAT)

Kestra Medical Technologies, Ltd. and LeMaitre Vascular, Inc. are both Medical Instruments & Supplies companies. LeMaitre Vascular, Inc. is the larger, with a market value of $1.9B against $1.5B — 1.2× the size. Kestra Medical Technologies, Ltd. has negative trailing earnings, so its P/E is not meaningful; LeMaitre Vascular, Inc. trades at 28.1×. Kestra Medical Technologies, Ltd. grew revenue faster over the last twelve months: 60.7% against 11.9%. LeMaitre Vascular, Inc. has the higher net margin (25.0% vs −140.4%) and the higher return on invested capital (22.7% vs −93.5%). Across the 17 metrics below, LeMaitre Vascular, Inc. leads on 14 and Kestra Medical Technologies, Ltd. on 3.

Valuation

Metric KMTS LMAT Medical Instruments & Supplies median
P/E n/m 28.11 34.17
P/S 14.89 7.10 2.83
P/B 7.15 4.43 2.82
Price to free cash flow n/m 25.25 25.69
EV/EBITDA n/m 18.70 16.08
EV/Sales 13.71 6.32 3.06
Earnings yield (9.85%) 3.56% (1.84%)
Free cash flow yield (7.74%) 3.96% 0.17%

Profitability

Metric KMTS LMAT Medical Instruments & Supplies median
Gross margin 53.89% 72.90% 54.62%
Operating margin (134.48%) 29.46% 1.64%
Net margin (140.43%) 25.02% 0.00%
Free cash flow margin (115.31%) 28.13% 1.61%
Return on equity (73.74%) 16.77% 0.00%
Return on assets (48.85%) 10.78% 0.00%
Return on invested capital (93.49%) 22.67% 0.00%

Growth

Metric KMTS LMAT Medical Instruments & Supplies median
Revenue growth (TTM) 60.72% 11.85% 9.20%
EPS growth (last fiscal year) 52.63% 30.57% —
Revenue growth, 5-year CAGR — 14.05% 9.48%
Net income growth, 5-year CAGR — 22.16% 0.00%

Health

Metric KMTS LMAT Medical Instruments & Supplies median
Debt to equity 0.33 0.40 0.08
Current ratio 4.69 16.31 2.49
Net debt to EBITDA 1.24 (2.40) 0.83

Dividend

Metric KMTS LMAT Medical Instruments & Supplies median
Dividend yield — 0.92% 0.99%
Payout ratio — 0.47 0.00

Size

Metric KMTS LMAT Medical Instruments & Supplies median
Market cap 1.53b 1.85b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack